Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
39%

OVERLAP
BY WEIGHT
21

# OF OVERLAPPING
HOLDINGS
PJP
29
HOLDINGS
72%
ALSO IN XPH
XPH
55
HOLDINGS
43%
ALSO IN PJP
SECTOR DRIFT (PJP minus XPH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PJP
Weight
in XPH
Overlap
SUPERNUS PHARMACEUTICALS INC 2.8% 2.0% 2.0%
MERCK & CO. INC. 5.0% 2.0% 2.0%
ELI LILLY & CO 5.4% 2.0% 2.0%
BRISTOL-MYERS SQUIBB CO 2.5% 1.9% 1.9%
LIGAND PHARMACEUTICALS-CL B 2.9% 1.9% 1.9%
PJP Overweight Relative to XPH
ABBVIE INC 5.3%
AMGEN INC 4.9%
ABBOTT LABORATORIES 4.9%
GILEAD SCIENCES INC 4.7%
UNITED THERAPEUTICS CORP 3.8%
TRAVERE THERAPEUTICS, INC. 3.7%
ELI LILLY & CO 3.4%
PFIZER INC 3.4%
JOHNSON & JOHNSON 3.2%
BIOGEN IDEC INC 3.0%
PJP Underweight Relative to XPH
NUVATION BIO INC CLASS A -2.2%
EDGEWISE THERAPEUTICS, INC. -2.0%
EYEPOINT PHARMACEUTICALS INC -2.0%
ZOETIS INC -1.9%
ELANCO ANIMAL HEALTH, INC. -1.9%
ESPERION THERAPEUTICS INC -1.9%
LIQUIDIA TECHNOLOGIES, INC. -1.9%
PHATHOM PHARMACEUTICALS, INC. -1.9%
ROYALTY PHARMA PLC CLASS A -1.9%
AXSOME THERAPEUTICS, INC. -1.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY